Cellares Stock
HealthTechLooking to sell Cellares stock or options?
Cellares is a dedicated Integrated Development and Manufacturing Organization, striving to expedite the availability of life-saving cell therapies for patients. This company is at the forefront of developing and implementing integrated cell therapy manufacturing technologies. This not only accelerates the pace of drug development but also facilitates manufacturing scale-out, thereby fulfilling global patient demand. Cellares works in collaboration with academic institutions, biotech firms, and pharmaceutical companies, facilitating faster drug development.
Koch Disruptive Technologies, DFJ Growth, Skyviews Life Science, 8VC, Eclipse Ventures, Bristol-Myers Squibb, Trinity Capital, Decheng Capital, EcoR1 Capital, Willett Advisors.